Can genomics help developing countries face their growing burden of disease?

c de e z
Credit: Flickr/US Army Africa

Genomics has the potential to help developing countries tackle the double burden of infectious and non-infectious diseases. But for low-income countries, the most obvious barrier to adoption is financial: establishing genomics as a part of the health service is expensive, and requires sustainable funding as well as political will. In addition, low-income countries may not have the necessary health care infrastructure and skilled human resources.

View the original article here: Delivering the promise of public health genomics

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend